ES2887338T3 - Uso de un compuesto de carbamato para prevenir o tratar la neuralgia del trigémino - Google Patents

Uso de un compuesto de carbamato para prevenir o tratar la neuralgia del trigémino Download PDF

Info

Publication number
ES2887338T3
ES2887338T3 ES17799674T ES17799674T ES2887338T3 ES 2887338 T3 ES2887338 T3 ES 2887338T3 ES 17799674 T ES17799674 T ES 17799674T ES 17799674 T ES17799674 T ES 17799674T ES 2887338 T3 ES2887338 T3 ES 2887338T3
Authority
ES
Spain
Prior art keywords
compound
trigeminal
pharmaceutical composition
trigeminal neuralgia
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES17799674T
Other languages
English (en)
Spanish (es)
Inventor
Min Jae Jo
Sun Gwan Hwang
Han Ju Yi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SK Biopharmaceuticals Co Ltd
Original Assignee
SK Biopharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SK Biopharmaceuticals Co Ltd filed Critical SK Biopharmaceuticals Co Ltd
Application granted granted Critical
Publication of ES2887338T3 publication Critical patent/ES2887338T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES17799674T 2016-05-19 2017-05-18 Uso de un compuesto de carbamato para prevenir o tratar la neuralgia del trigémino Active ES2887338T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160061386 2016-05-19
PCT/KR2017/005172 WO2017200317A1 (ko) 2016-05-19 2017-05-18 삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Publications (1)

Publication Number Publication Date
ES2887338T3 true ES2887338T3 (es) 2021-12-22

Family

ID=60325324

Family Applications (1)

Application Number Title Priority Date Filing Date
ES17799674T Active ES2887338T3 (es) 2016-05-19 2017-05-18 Uso de un compuesto de carbamato para prevenir o tratar la neuralgia del trigémino

Country Status (14)

Country Link
US (1) US11207295B2 (https=)
EP (1) EP3459542B1 (https=)
JP (1) JP6960415B2 (https=)
KR (1) KR102421013B1 (https=)
CN (1) CN109310669B (https=)
AU (1) AU2017267160B2 (https=)
CA (1) CA3024284C (https=)
DK (1) DK3459542T3 (https=)
ES (1) ES2887338T3 (https=)
MX (1) MX389613B (https=)
PL (1) PL3459542T3 (https=)
PT (1) PT3459542T (https=)
RU (1) RU2751504C2 (https=)
WO (1) WO2017200317A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3556365B1 (en) * 2016-12-14 2025-07-02 SK Biopharmaceuticals Co., Ltd. Use of carbamate compound for prevention, alleviation, or treatment of demyelinating disease
ES2978226T3 (es) * 2018-09-21 2024-09-09 Sk Biopharmaceuticals Co Ltd Compuesto de carbamato y uso de la formulación que lo comprende para prevenir, aliviar o tratar el trastorno de estrés agudo o el trastorno de estrés postraumático
AU2019361856B2 (en) * 2018-10-19 2024-11-07 Sk Biopharmaceuticals Co., Ltd. Use of carbamate compound for preventing, alleviating or treating diabetic peripheral neuropathy or chemotherapy-induced peripheral neuropathy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3415840A (en) 1965-10-22 1968-12-10 American Home Prod Pyrazole-1-ethanol derivatives
DE2628420A1 (de) * 1976-06-24 1978-01-05 Bayer Ag 1-acyloxy-2-imidazolyl-1-phenyl- aethane, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und nematizide
IL157593A0 (en) * 2001-02-27 2004-03-28 Ortho Mcneil Pharm Inc Carbamate compounds for use in the treatment of pain
US7598279B2 (en) * 2005-04-22 2009-10-06 Sk Holdings Co., Ltd. Neurotherapeutic azole compounds
JP4227121B2 (ja) 2005-06-08 2009-02-18 独立行政法人科学技術振興機構 神経因性疼痛治療剤
WO2010150946A1 (en) 2009-06-22 2010-12-29 Sk Holdings Co., Ltd. Method for preparation of carbamic acid (r)-1-aryl-2-tetrazolyl-ethyl ester
US8404461B2 (en) 2009-10-15 2013-03-26 SK Biopharmaceutical Co. Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
CA2817290A1 (en) * 2010-11-11 2012-05-18 Josef Penninger Compounds and methods for treating pain
MX368735B (es) 2014-05-09 2019-10-14 Tecnimede Sociedade Tecnico Medicinal S (r)-pirlindol y sus sales farmaceuticamente aceptables para uso en medicina.

Also Published As

Publication number Publication date
WO2017200317A1 (ko) 2017-11-23
RU2751504C2 (ru) 2021-07-14
CN109310669B (zh) 2022-02-22
KR102421013B1 (ko) 2022-07-14
EP3459542A4 (en) 2020-01-08
KR20170131241A (ko) 2017-11-29
US11207295B2 (en) 2021-12-28
JP6960415B2 (ja) 2021-11-05
PL3459542T3 (pl) 2021-12-27
AU2017267160A1 (en) 2018-12-13
AU2017267160B2 (en) 2022-11-10
RU2018144784A (ru) 2020-06-19
PT3459542T (pt) 2021-08-24
MX2018014081A (es) 2019-09-02
US20190175555A1 (en) 2019-06-13
CA3024284A1 (en) 2017-11-23
US20220087976A1 (en) 2022-03-24
DK3459542T3 (da) 2021-09-13
EP3459542B1 (en) 2021-06-30
RU2018144784A3 (https=) 2020-08-11
CA3024284C (en) 2024-01-23
JP2019516722A (ja) 2019-06-20
MX389613B (es) 2025-03-20
EP3459542A1 (en) 2019-03-27
BR112018073556A2 (pt) 2019-03-19
CN109310669A (zh) 2019-02-05

Similar Documents

Publication Publication Date Title
ES2743153T3 (es) Métodos para tratar el síndrome de fibromialgia
JP7071287B2 (ja) 繊維筋痛又は繊維筋痛の関連する機能的症候群を予防又は治療するためのカルバメート化合物の使用
ES2887338T3 (es) Uso de un compuesto de carbamato para prevenir o tratar la neuralgia del trigémino
JP7578747B2 (ja) 欠神発作又は欠神発作を示すてんかんの予防、軽減又は治療のためのカルバメート化合物の使用
KR102921943B1 (ko) 중첩발작의 예방, 경감 또는 치료에 대한 카바메이트 화합물의 용도
BR112019011930A2 (pt) medicamento, composição farmacêutica, método para prevenir, aliviar ou tratar transtorno bipolar em um indivíduo, e, uso de um composto de carbamato.
ES3039979T3 (en) Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndrome
US12611395B2 (en) Use of carbamate compound for preventing or treating trigeminal neuralgia
ES2207544T3 (es) Derivados de 2-aminotetralina para la terapia del glaucoma.
BR112018073556B1 (pt) Uso de um composto de carbamato
KR20210062029A (ko) 카바메이트 화합물의 당뇨병성 말초 신경병증 또는 화학요법 유발 말초 신경병증의 예방, 완화 또는 치료를 위한 용도
RU2787771C2 (ru) Применение карбаматного производного для предотвращения, облегчения или лечения малого эпилептического припадка или эпилепсии, проявляющей малый эпилептический припадок
HK40003859B (en) Use of carbamate compound for preventing or treating trigeminal neuralgia
HK40003859A (en) Use of carbamate compound for preventing or treating trigeminal neuralgia
JO et al. Use of carbamate compound for preventing or treating trigeminal neuralgia
HK40005640A (en) Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia
HK40005640B (en) Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia